Dr. Krishna V. Komanduri Named President-Elect of Transplantation Society
Sylvester Comprehensive Cancer Center, part of UHealth – the University of Miami Health System, has announced that Krishna V. Komanduri, M.D., Director of the Adult Stem Cell Transplant Program and Kalish Family Chair in Stem Cell Transplantation, was recently named President-Elect of the American Society for Blood and Marrow Transplantation (ASBMT).
“I am pleased and humbled by this vote of confidence in me by the ASBMT officers, directors and members,” said Komanduri, who is also professor of medicine and microbiology and immunology at the University of Miami Miller School of Medicine. “As President-Elect of the ASBMT, I will work with members from across the country and the globe to improve the application and success of blood and marrow transplantation, as well as related cellular therapies. Together, we will promote research, education and clinical practice.”
Komanduri joined Sylvester in 2008 from MD Anderson Cancer Center in Houston, Texas. Under his leadership, the Adult Stem Cell Transplant Program has grown significantly in recent years. He and his team have performed more than 600 transplants, and the program is expected to perform more than 200 transplants in 2016. In addition, he and his team have been instrumental in the development of immunotherapy trials at Sylvester, including recent promising, high-profile trials of T cells targeting blood cancers.
“The addition of Dr. Komanduri to the executive committee of the ASBMT as President-Elect positions the society well to deal with the rapid evolution of cellular therapies,” said Christopher Bredeson, M.D., M.Sc., president of the ASBMT. “His recognized excellence as a scientist and his experience building a successful research-focused transplant program will help inform the important decisions that ASBMT faces in the next few years. I am very pleased to have him as a partner in this mission.”
The ASBMT is an international professional membership association of more than 2,000 physicians, investigators and other health care professionals in the blood and marrow transplantation field from more than 45 countries.